Engineered virus platform

Newcastle disease virus

Newcastle disease virus replicates preferentially in tumor cells and has a strong record as an oncolytic and immunostimulatory agent in research settings. FuBio propagates NDV vectors carrying reporter genes for replication tracking.

  • Intrinsic tumor selectivity

    Defective interferon responses in tumor cells favor NDV replication.

  • Reporter constructs

    GFP-carrying NDV for direct visualization of infection and spread.

  • Immunostimulatory profile

    Strong type I interferon induction, relevant to combination immunotherapy research.

  • Propagation and titration

    Amplification in embryonated eggs or cell culture with titer determination.

Typical applications

  • Oncolytic virus efficacy screening
  • Innate immune response research
  • Combination studies with immune checkpoint research tools
  • Viral replication tracking in vitro and in vivo

Specifications

Catalog constructs
Reporter-carrying NDV available
Volume
1 mL
Promoter
Endogenous NDV promoter
Custom engineering
Transgene insertion on request

Others in Oncolytic Virus

  • Oncolytic adenovirus

    Oncolytic adenoviruses are the most widely used oncolytic platform. FuBio supplies adenoviral constructs with...

  • Herpes simplex virus

    Herpes simplex virus type 1 offers a large genome and a well-characterized replication cycle, which makes it...

  • Vesicular stomatitis virus

    Vesicular stomatitis virus is a fast-replicating, cytoplasmically replicating vector widely used to study...

Need a specification or a quotation?

Send the vector, payload and scale you need. We reply with feasibility, lead time and price within one business day.

Request a Quote